Annual D&A
$41.85 M
+$6.57 M+18.61%
31 December 2023
Summary:
Akebia Therapeutics annual depreciation & amortization is currently $41.85 million, with the most recent change of +$6.57 million (+18.61%) on 31 December 2023. During the last 3 years, it has risen by +$9.19 million (+28.15%). AKBA annual D&A is now at all-time high.AKBA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$9.37 M
-$36.00 K-0.38%
30 September 2024
Summary:
Akebia Therapeutics quarterly depreciation & amortization is currently $9.37 million, with the most recent change of -$36.00 thousand (-0.38%) on 30 September 2024. Over the past year, it has dropped by -$33.00 thousand (-0.35%). AKBA quarterly D&A is now -3.70% below its all-time high of $9.73 million, reached on 30 September 2019.AKBA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$37.56 M
-$33.00 K-0.09%
30 September 2024
Summary:
Akebia Therapeutics TTM depreciation & amortization is currently $37.56 million, with the most recent change of -$33.00 thousand (-0.09%) on 30 September 2024. Over the past year, it has dropped by -$79.00 thousand (-0.21%). AKBA TTM D&A is now -3.02% below its all-time high of $38.73 million, reached on 31 March 2020.AKBA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.6% | -0.3% | -0.2% |
| 3 y3 years | +28.1% | -1.2% | +0.6% |
| 5 y5 years | +1628.5% | -3.7% | +22.2% |
AKBA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +28.1% | -1.2% | at low | -1.1% | +0.6% |
| 5 y | 5 years | at high | +1628.5% | -3.7% | +41.6% | -3.0% | +22.2% |
| alltime | all time | at high | -3.7% | -3.0% |
Akebia Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.37 M(-0.4%) | $37.56 M(-0.1%) |
| June 2024 | - | $9.41 M(+0.4%) | $37.60 M(+0.0%) |
| Mar 2024 | - | $9.38 M(-0.3%) | $37.59 M(-0.1%) |
| Dec 2023 | $41.85 M(+18.6%) | $9.40 M(-0.0%) | $37.63 M(-0.0%) |
| Sept 2023 | - | $9.41 M(0.0%) | $37.64 M(-0.0%) |
| June 2023 | - | $9.41 M(-0.0%) | $37.66 M(-0.1%) |
| Mar 2023 | - | $9.41 M(-0.1%) | $37.68 M(-0.1%) |
| Dec 2022 | $35.28 M(-2.3%) | $9.42 M(-0.1%) | $37.70 M(-0.1%) |
| Sept 2022 | - | $9.42 M(-0.0%) | $37.73 M(-0.2%) |
| June 2022 | - | $9.43 M(-0.0%) | $37.79 M(-0.2%) |
| Mar 2022 | - | $9.43 M(-0.3%) | $37.87 M(-0.3%) |
| Dec 2021 | $36.13 M(+10.6%) | $9.45 M(-0.3%) | $37.97 M(+1.7%) |
| Sept 2021 | - | $9.48 M(-0.3%) | $37.34 M(+8.3%) |
| June 2021 | - | $9.51 M(-0.2%) | $34.48 M(-0.3%) |
| Mar 2021 | - | $9.52 M(+7.9%) | $34.59 M(-0.3%) |
| Dec 2020 | $32.66 M(-10.3%) | $8.83 M(+33.3%) | $34.69 M(-2.4%) |
| Sept 2020 | - | $6.62 M(-31.2%) | $35.55 M(-8.1%) |
| June 2020 | - | $9.62 M(-0.0%) | $38.67 M(-0.2%) |
| Mar 2020 | - | $9.63 M(-0.6%) | $38.73 M(+0.2%) |
| Dec 2019 | $36.42 M(+1404.2%) | $9.69 M(-0.5%) | $38.65 M(+25.7%) |
| Sept 2019 | - | $9.73 M(+0.5%) | $30.74 M(+44.8%) |
| June 2019 | - | $9.69 M(+1.6%) | $21.23 M(+80.5%) |
| Mar 2019 | - | $9.54 M(+435.0%) | $11.76 M(+385.8%) |
| Dec 2018 | $2.42 M | $1.78 M(+692.4%) | $2.42 M(+189.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $225.00 K(+5.1%) | $835.00 K(+7.5%) |
| June 2018 | - | $214.00 K(+7.5%) | $777.00 K(+14.1%) |
| Mar 2018 | - | $199.00 K(+1.0%) | $681.00 K(+10.4%) |
| Dec 2017 | $617.00 K(+108.4%) | $197.00 K(+18.0%) | $617.00 K(+13.4%) |
| Sept 2017 | - | $167.00 K(+41.5%) | $544.00 K(+15.5%) |
| June 2017 | - | $118.00 K(-12.6%) | $471.00 K(+18.0%) |
| Mar 2017 | - | $135.00 K(+8.9%) | $399.00 K(+34.8%) |
| Dec 2016 | $296.00 K(+208.3%) | $124.00 K(+31.9%) | $296.00 K(+61.7%) |
| Sept 2016 | - | $94.00 K(+104.3%) | $183.00 K(+47.6%) |
| June 2016 | - | $46.00 K(+43.8%) | $124.00 K(+13.8%) |
| Mar 2016 | - | $32.00 K(+190.9%) | $109.00 K(+13.5%) |
| Dec 2015 | $96.00 K(+95.9%) | $11.00 K(-68.6%) | $96.00 K(-5.0%) |
| Sept 2015 | - | $35.00 K(+12.9%) | $101.00 K(+27.8%) |
| June 2015 | - | $31.00 K(+63.2%) | $79.00 K(+31.7%) |
| Mar 2015 | - | $19.00 K(+18.8%) | $60.00 K(+22.4%) |
| Dec 2014 | $49.00 K(+4800.0%) | $16.00 K(+23.1%) | $49.00 K(+44.1%) |
| Sept 2014 | - | $13.00 K(+8.3%) | $34.00 K(+61.9%) |
| June 2014 | - | $12.00 K(+50.0%) | $21.00 K(+133.3%) |
| Mar 2014 | - | $8000.00(+700.0%) | $9000.00(+800.0%) |
| Dec 2013 | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Sept 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $0.00 | - | - |
FAQ
- What is Akebia Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Akebia Therapeutics?
- What is Akebia Therapeutics annual D&A year-on-year change?
- What is Akebia Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly D&A year-on-year change?
- What is Akebia Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Akebia Therapeutics?
- What is Akebia Therapeutics TTM D&A year-on-year change?
What is Akebia Therapeutics annual depreciation & amortization?
The current annual D&A of AKBA is $41.85 M
What is the all time high annual D&A for Akebia Therapeutics?
Akebia Therapeutics all-time high annual depreciation & amortization is $41.85 M
What is Akebia Therapeutics annual D&A year-on-year change?
Over the past year, AKBA annual depreciation & amortization has changed by +$6.57 M (+18.61%)
What is Akebia Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AKBA is $9.37 M
What is the all time high quarterly D&A for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly depreciation & amortization is $9.73 M
What is Akebia Therapeutics quarterly D&A year-on-year change?
Over the past year, AKBA quarterly depreciation & amortization has changed by -$33.00 K (-0.35%)
What is Akebia Therapeutics TTM depreciation & amortization?
The current TTM D&A of AKBA is $37.56 M
What is the all time high TTM D&A for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM depreciation & amortization is $38.73 M
What is Akebia Therapeutics TTM D&A year-on-year change?
Over the past year, AKBA TTM depreciation & amortization has changed by -$79.00 K (-0.21%)